DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TYSABRI (natalizumab)
       *****************************************************
       #Post#: 3082--------------------------------------------------
       (Abst.) Tysabri better than Gilenya in achieving "no
       evidence of disease activity"
   DIR By: agate
       Date: November 11, 2020, 12:38 am
       ---------------------------------------------------------
       From PubMed (October 30, 2020), "BEST-MS:  A prospective
       head-to-head comparative study of natalizumab and fingolimod in
       active relapsing MS":
  HTML https://pubmed.ncbi.nlm.nih.gov/33124504/
       *****************************************************
       Page 1 of 1